​

Boston Scientific (BSX) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

BSX Stock Forecast


Boston Scientific (BSX) stock forecast, based on 44 Wall Street analysts, predicts a 12-month average price target of $53.77, with a high of $71.00 and a low of $44.00. This represents a 23.21% increase from the last price of $43.64.

$40 $53 $66 $79 $92 $105 High: $71 Avg: $53.77 Low: $44 Last Closed Price: $43.64

BSX Stock Rating


Boston Scientific stock's rating consensus is Buy, based on 44 Wall Street analysts. The breakdown includes 1 Strong Buy (2.27%), 33 Buy (75.00%), 10 Hold (22.73%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 44 10 33 1 Strong Sell Sell Hold Buy Strong Buy

BSX Price Target Upside V Benchmarks


TypeNameUpside
StockBoston Scientific23.21%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks9.18%

Price Target Trends


1M3M12M
# Anlaysts111884
Avg Price Target$48.73$50.72$78.07
Last Closing Price$43.64$43.64$43.64
Upside/Downside11.66%16.22%78.90%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 2661411--31
Oct, 268176--31
Sep, 268185--31
Aug, 268194--31
Jul, 267194--30
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 30, 2026Joshua JenningsTD Cowen$46.00$41.989.58%5.41%
Oct 29, 2026RBC Capital$52.00$42.2922.96%19.16%
Oct 29, 2026Deutsche Bank$48.00$42.2713.56%9.99%
Oct 29, 2026BTIG$49.00$42.4315.48%12.28%
Oct 29, 2026Mike KratkyLeerink Partners$50.00$42.4317.84%14.57%
Oct 29, 2026Anthony PetroneMizuho Securities$50.00$42.4317.84%14.57%
Oct 29, 2026William PlovanicCanaccord Genuity$48.00$42.4313.13%9.99%
Oct 28, 2026Jefferies$46.00$42.438.41%5.41%
Oct 28, 2026Needham$48.00$43.0311.55%9.99%
Oct 26, 2026Stifel Nicolaus$55.00$45.6920.38%26.03%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Oct 29, 2026RBC CapitalOutperformOutperformhold
Oct 29, 2026CitigroupNeutralNeutralhold
Oct 29, 2026OppenheimerOutperformPerformdowngrade
Oct 28, 2026JefferiesBuyHolddowngrade
Oct 20, 2026Cowen & Co.BuyBuyhold
Oct 06, 2026BarclaysOverweightPositiveinitialise
Oct 06, 2026BarclaysOverweightUnderweightinitialise
Oct 03, 2026BernsteinOutperformOutperformhold
Sep 21, 2026OppenheimerOutperformOutperformhold
Sep 17, 2026Cowen & Co.BuyBuyhold

Financial Forecast


EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.69$0.45$1.08$1.26$1.96---
Avg Forecast$1.61$1.73$2.01$2.47$2.81$3.20$3.56$3.96
High Forecast$1.65$1.78$2.02$2.48$2.86$3.93$4.46$4.08
Low Forecast$1.59$1.68$2.00$2.46$2.76$2.46$2.61$3.80
Surprise %-57.14%-73.99%-46.27%-48.99%-30.25%---

Revenue Forecast

$10B $14B $18B $22B $26B $30B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.89B$12.68B$14.24B$16.75B$20.07B---
Avg Forecast$11.87B$12.68B$14.12B$16.61B$18.79B$20.70B$22.61B$24.63B
High Forecast$12.08B$12.97B$14.13B$16.68B$19.18B$20.70B$22.67B$25.22B
Low Forecast$11.73B$12.36B$14.08B$16.54B$18.30B$20.70B$22.54B$23.83B
Surprise %0.12%-0.02%0.88%0.83%6.83%---

Net Income Forecast

$500M $2B $3B $4B $6B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.04B$698.00M$1.59B$1.85B$2.89B---
Avg Forecast$947.28M$909.12M$1.57B$3.61B$4.11B$4.68B$3.93B$5.80B
High Forecast$1.14B$1.09B$1.88B$3.62B$4.19B$5.76B$6.52B$5.98B
Low Forecast$757.83M$727.30M$1.26B$3.59B$4.04B$3.60B$3.81B$5.55B
Surprise %9.79%-23.22%1.46%-48.62%-29.84%---

BSX Forecast FAQ


Is Boston Scientific stock a buy?

Boston Scientific stock has a consensus rating of Buy, based on 44 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 33 Buy, 10 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Boston Scientific is a favorable investment for most analysts.

What is Boston Scientific's price target?

Boston Scientific's price target, set by 44 Wall Street analysts, averages $53.77 over the next 12 months. The price target range spans from $44 at the low end to $71 at the high end, suggesting a potential 23.21% change from the previous closing price of $43.64.

How does Boston Scientific stock forecast compare to its benchmarks?

Boston Scientific's stock forecast shows a 23.21% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (9.18%).

What is the breakdown of analyst ratings for Boston Scientific over the past three months?

  • November 2026: 19.35% Strong Buy, 45.16% Buy, 35.48% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 25.81% Strong Buy, 54.84% Buy, 19.35% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 25.81% Strong Buy, 58.06% Buy, 16.13% Hold, 0% Sell, 0% Strong Sell.

What is Boston Scientific’s EPS forecast?

Boston Scientific's average annual EPS forecast for its fiscal year ending in December 2026 is $3.2, marking a 63.27% increase from the reported $1.96 in 2025. Estimates for the following years are $3.56 in 2027, and $3.96 in 2028.

What is Boston Scientific’s revenue forecast?

Boston Scientific's average annual revenue forecast for its fiscal year ending in December 2026 is $20.7B, reflecting a 3.10% increase from the reported $20.07B in 2025. The forecast for 2027 is $22.61B, and $24.63B for 2028.

What is Boston Scientific’s net income forecast?

Boston Scientific's net income forecast for the fiscal year ending in December 2026 stands at $4.68B, representing an 62.16% increase from the reported $2.89B in 2025. Projections indicate $3.93B in 2027, and $5.8B in 2028.